Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0473 per EA under NDC 70954000520. Its NADAC has been published 421 times since Jun 6, 2018.
Strength
5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954000520
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209823On Market Since
11/15/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 421 times since Jun 6, 2018, and over the history we have for it it has declined 79.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.2261 (Jun 13, 2018) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.0721 |
| Average price | $0.0893 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 421 |
| Tracking since | Jun 6, 2018 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.0473 per EA (NDC 70954000520), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 79.1%. It has been tracked across 421 weekly CMS publications since Jun 6, 2018.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Jun 6, 2018, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.2261 (Jun 13, 2018), with a median of $0.0721 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 70954000520) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification